It recently was announced that two leaders in cardiovascular disease science, research and education — the American Heart Association (AHA) and the Cardiovascular Research Foundation (CRF) — are joining forces, which will help strengthen and expand educational opportunities in cardiovascular disease and interventional therapies. This new alliance will begin this fall, at both organizations’ annual scientific meetings.
The AHA will present educational programming from its annual Scientific Sessions at TCT, and CRF will deliver educational programming from its annual scientific symposium Transcatheter Cardiovascular Therapeutics (TCT) at the Association’s Scientific Sessions. This will kick off at TCT 2022, which is being held Sept. 16-19 in Boston.
“This important collaboration with our esteemed CRF colleagues will enrich the educational offerings available at TCT and our Scientific Sessions, further strengthening our quest to improve the quality of cardiovascular care and patient outcomes,” said the AHA’s Chief Executive Officer Nancy Brown in a written statement. “Harnessing the strengths of our two pioneering organizations with extensive experience in translating the latest scientific breakthroughs into practical therapies is crucial. Together, we aim to boost the pace of knowledge, research and expertise within the cardiovascular disease and cardiac interventional therapy communities to help transform cardiovascular care for patients all over the world, particularly as we continue to navigate the COVID-19 pandemic and its still-to-be-uncovered impacts throughout the body and especially the heart.”
CRF’s President and Chief Executive Officer Juan F. Granada, MD, added: “With visionary thinking and bold action, we can tackle health care’s biggest challenges and improve cardiovascular care and outcomes. This collaboration will foster innovative research and education by bringing together world-renowned experts in the field to identify and advance the most promising science in cardiology and interventional cardiology. The future of our profession and the health of our patients will be brighter because of this collective effort.”
At TCT 2022, the AHA will present Best Practices sessions focused on clinical guidelines and vascular care. The Association’s Scientific Sessions leaders will share live highlights of TCT from the World Connect studio. CRF will present several sessions at the Association’s Scientific Sessions 2022, November 5-7 in Chicago.
“This collaboration will forge a unique bridge and provide novel points of connection, knowledge-sharing, mentorship and advancement that will help drive diversity of experience and understanding among cardiovascular clinicians and interventional specialists around the world,” said the Association’s Chief science and medical officer Mariell Jessup, M.D., FAHA, in a press release. “With the tremendous synergy and significant expertise among our clinicians, surgeons, interventionalists and specialists, our new alliance will lead the way in the next generation of scientific education programs through innovative learning experiences.”